Navigation Links
First Ever National Biovigilance Network in the U.S. Reaches $1 Million in Funding, Prepares for Fall Pilot Launch
Date:7/16/2008

Network Data and Analysis Will Greatly Enhance Patient Safety and Reduce Healthcare Costs

BETHESDA, Md., July 16 /PRNewswire-USNewswire/ -- The U.S. Biovigilance Network, the nation's first and only nationwide data collection program for the transfusion and biological therapy communities, is preparing for a fall 2008 launch of its pilot. The Network has raised more than $1 million in private donations, including an $84,000 contribution by Fenwal Inc., one of the community's medical technology leaders. It has also secured support from hospitals and blood centers across the country.

The Network is a unique public/private collaboration with shared responsibilities for program development, operation and management, and funding. The federal government, through the Department of Health and Human Services, including the Centers for Disease Control and Prevention, has provided the platform for initial surveillance efforts through its National Healthcare Safety Network. The U.S. Biovigilance Network has raised $1 million in private contributions to fund the initial expenses and is seeking $2 million in additional support to complete development and implement the program.

"To ensure the safety of America's blood supply, it is vital that we create a centralized and standardized process for reporting adverse events," said Barbee Whitaker, Ph.D., AABB's Director of Data and Special Programs. "With data from the U.S. Biovigilance Network, we will be able to create a quality system that benefits patients, donors and the public health of the U.S."

The U.S. Biovigilance Network will, for the first time on a nationwide basis, collect and analyze data to identify trends and recommend best practices to reduce adverse reactions and incidents associated with blood transfusion and related biological therapies. Ultimately, the analyses of these data will enhance patient safety, make better use of blood and biological therapies, and reduce healthcare costs.

"This has the potential to be a significant advancement, benefiting both patients and donors," said Ron K. Labrum, President and CEO of Fenwal Inc. "By standardizing and validating comprehensive information on the safety of transfusion medicine, biovigilance can provide a critical early-warning system that benefits patients and helps focus health-care innovators on those issues most critical to improving health-care outcomes."

The first stage of the pilot phase will be implemented with nine hospitals across the country. This phase will allow for fine-tuning of the surveillance system and analysis of initial data collected. Additional organizations are voluntarily registering to contribute data, with full participation and system launch anticipated in 2009.

The U.S. is the only developed nation that does not have a national system to track and monitor the safety of blood collection and transfusion. To date, the U.S. has relied on information from hemovigilance systems in other countries and on tracking by individual hospitals, transfusing organizations and blood centers. The challenge is that these results are not widely shared and common conclusions cannot be drawn. This results in the loss of an opportunity to learn from adverse events that may happen in more than one place and reduces the likelihood that the events can be prevented elsewhere. By contrast, those countries with surveillance systems have lower morbidity and mortality rates for patients and donors.

Hospitals, blood centers and other facilities will use the U.S. Biovigilance Network to report adverse events and unexpected reactions and incidents related to transfusion medicine. Analysis of this data will lead to process improvements which may lead to new standards of quality and safety for the collection, testing, processing, storage, distribution and transfusion of blood and use of related biological therapies. It will also allow for the design of interventions that can be adopted nationally.

"The U.S. Biovigilance Network is one of the most important initiatives to advance patient safety and reduce costs within our community," said Karen Shoos Lipton, AABB's CEO. "The financial support we have received is a powerful endorsement of the Network's value and of the community's commitment to its patients and to the public health of our country. We thank our supporters for their contributions and hope others will follow the example set by their leadership."

Private sector organizations that have pledged their financial support of the U.S. Biovigilance Network include:

AABB

American Red Cross

Blood Bank of Alaska

Blood Bank of Hawaii

Blood Centers of the Pacific

Blood Systems, Inc.

BloodCenter of Wisconsin

Bonfils Blood Center

Cascade Regional Blood Services

Central Illinois Community Blood Center

Central Pennsylvania Blood Bank

Coffee Memorial Blood Center

Community Blood Bank (NE)

Community Blood Center (Appleton)

Community Blood Center (Kansas City)

Community Blood Center (Wisconsin)

Community Blood Center of the Carolinas

Community Blood Center/Community Tissue Services

Community Blood Services of Illinois

Dartmouth-Hitchcock Medical Centers

Fenwal, Inc.

Heartland Blood Centers

Indiana Blood Center

Inland Northwest Blood Center

Institute for Transfusion Medicine

Lane Memorial Blood Bank

Lifeline Blood Services/West Tennessee

Regional Blood Center

LifeShare Community Blood Services

Memorial Blood Centers

Mississippi Blood Services

Mississippi Valley Regional Blood Center

Rhode Island Blood Center

Rock River Valley Blood Center

Texoma Regional Blood Center

The Blood Connection

Western Kentucky Regional Blood Center

"The quality gurus say 'If you can't measure it, you can't improve it,'" stated Dr. James AuBuchon, Chair of Pathology, Dartmouth-Hitchcock Medical Center. "The U.S. Biovigilance Network will allow us to see what's happening in transfusion and transplantation, use experts to analyze the situation, and recommend improvements in the system leading to augmented patient safety."

In addition, the U.S. Biovigilance Network has commitments to participate from facilities that account for approximately 20 percent of the transfusion activity in the U.S. Organizations that have agreed to contribute data to the Network include:

American Red Cross

Aurora St. Luke's Medical Center

Baystate Medical Center

Children's Healthcare of Atlanta

Children's Hospital (Los Angeles)

Children's Hospital (Dallas)

Cleveland Clinic

Columbia University Hospital

Dartmouth Hitchcock Medical Center

Emory Crawford Long Hospital

Emory University

Euclid Hospital

Fairview Hospital

Fairview Southdale

Froedtert & the Medical College of Wisconsin

Fletcher Allen Health Care

Genesis Medical Center

Grady Memorial Hospital

Hahnemann Hospital

Hennepin County Medical Center

Hillcrest Hospital

Huron Hospital

The Johns Hopkins Hospital and Health System

Lakewood Hospital

Lutheran Hospital

Marymount Hospital

M. D. Anderson Cancer Center

New York Presbyterian Hospital

Puget Sound Blood Center

South Pointe Hospital

Underwood Memorial Hospital

University Hospital Case Medical Center

University of Texas Medical Branch

Yale-New Haven Hospital

The U.S. Biovigilance Network must build on its current momentum for its success in the long-term. The transfusion and biological therapies communities' help is needed to provide the critical data that will fuel the U.S. Biovigilance Network, to provide the startup capital, and to advocate for its development and sustained operation. For more information, please visit http://www.aabb.org/biovigilance.

About AABB

Established in 1947, AABB (formerly known as the American Association of Blood Banks) is an international, not-for-profit association dedicated to the advancement of science and the practice of transfusion medicine and related biological therapies. The association is committed to improving health by developing and delivering standards, accreditation and educational programs and services to optimize patient and donor care and safety. AABB membership consists of approximately 1,800 institutions and 8,000 individuals, including physicians, scientists, administrators, medical technologists, nurses, researchers, blood donor recruiters and public relations personnel. Members are located in all 50 states and 80 countries.


'/>"/>
SOURCE AABB
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Rep. Pickering to Receive First-Ever AVMA Advocacy Award
2. First International Cancer Film Festival Announces Finalists
3. Discovery first step to new therapies
4. Healthfirst and MD On-Line Partner to Streamline Claims Processing
5. Abaxis to Report First Quarter Fiscal 2009 Financial Results Thursday, July 24, 2008
6. Lutronic Announces FDA Clearance and Immediate Availability of Its eCO2, the First Multi-Functional Fractional CO2 Laser System
7. Stanford Bio-X researchers use needle-thin probe to get first look at working muscle fiber
8. Czech Republic to Host Historic First Global Conference on Methamphetamine
9. uKarma to Open First Xflowsion Fitness Studio With Celebrity Trainer Eric Paskel
10. leViv Launches First Meal Programs Specifically Designed for Taste and Health
11. Drexel School of Public Health Uses NetReachs cmScribe Advanced Content Management System (CMS) Software for First National Diversity Preparedness Clearinghouse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... 2016 , ... Research has shown that building shame resilience ... and level of relapse. , At the 2016 iaedp Symposium, the ... the critical tasks of the recovery phase and beyond including relapse prevention and ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... availability of the company's lighter, sleeker next generation LYNX VR Indoor Trainer with ... , Improvements in design and manufacturing not only reduce the weight of the ...
(Date:2/5/2016)... ... , ... The event is being held on April 7, 2016 from 5:30 ... Over Parkinson’s will fund nearly $100,000 for research for the care and cure of ... and is the architect of this informative event to raise awareness and funds for ...
(Date:2/5/2016)... ... February 05, 2016 , ... Looking for a last-minute Valentine’s Day ... tips of your toes. Foot massage, whether administered by a professional masseuse or a ... The American Board of Multiple Specialties in Podiatry (ABMSP) has taken the ...
(Date:2/5/2016)... Florida (PRWEB) , ... February 05, 2016 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – is poised to once again host, Swirl, A Wine Tasting Event at ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Worldwide Radiology ... significant growth as next generation systems provide a ... radiology for cancer surgery. New systems pinpoint the ... that has been such a problem previously, limiting ... Radiosurgery robots take cancer surgery far beyond what ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... Summary Global Markets Direct,s, ,Wegener Polyangiitis - ... the Wegener Polyangiitis,s therapeutic pipeline. This report ... Wegener Polyangiitis, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:2/4/2016)... , Feb. 4, 2016 Global ... competitive market to drive long-term market growth ... common set of chronic disorders that affect 5–7% ... in terms of their symptoms and key patient ... dysregulation of immune pathways and an inappropriate immune ...
Breaking Medicine Technology: